Keywords: DMC; dimethylcrocetin; CHD; coronary heart disease; LDL; low density lipoprotein; ROS; reactive oxygen species; PCa; prostate cancer; COX-2; cycloxygenase-2; NF-κB; nuclear factor-κB; RAR; retinoid-like receptors; PPARγ; Peroxisome proliferator-activat